Synexus


Clinical site network that operates global site locations and hybrid (on-site and remote) visits to support Phase I–IV clinical trials. Offers participant recruitment and enrollment services, sponsor-facing operational support, and a large identified patient database to enable scalable study execution and patient retention.

Industries

clinical-trials
consulting
health-care
medical

Nr. of Employees

large (251-1000)

Synexus

Tempe, Arizona, United States, North America


Products

Global clinical site network

Network of clinical research sites and associated operational capabilities used to deliver multicenter clinical studies.


Services

Online and site-based service to match patients and healthy volunteers to available clinical studies and manage enrollment logistics.

Operational execution across a multi-site network including recruitment, study visits, data capture, and sponsor oversight support.

Combination of central site visits and at-home or remote visits to support participant convenience and protocol flexibility.

Expertise Areas

  • Clinical trial management (Phase I–IV)
  • Participant recruitment and retention
  • Decentralized and hybrid trial delivery
  • Site network operations
  • Show More (3)

Key Technologies

  • Decentralized trial visit infrastructure (remote/home visits)
  • Patient identification and recruitment database
  • Clinical site network management systems
  • Clinical data capture and management systems
  • Show More (1)

News & Updates

Announcement that Synexus has become part of Trialmed, expanding the global clinical site network for Phase I–IV studies.

Operates over 250 high-performing clinical sites.

Organizational experience spanning over 40 years in clinical research.

More than 4,700 studies recruited to date.

Maintains an identified patient database of approximately 20 million for recruitment purposes.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.